amitabhchandra2's profile picture. Economist and Professor at HBS and HKS @Harvard. Tweets about food, dogs, piano, affogatos, India, and occasionally, health care.

Amitabh Chandra

@amitabhchandra2

Economist and Professor at HBS and HKS @Harvard. Tweets about food, dogs, piano, affogatos, India, and occasionally, health care.

Amitabh Chandra reposted

The controversial approval of a new $56,000-a-year #Alzheimers drug against the recommendation of an advisory committee of experts “highlights the importance of having an independent and well-resourced FDA," says @amitabhchandra2. commonwealthmagazine.org/drug-addiction…


Amitabh Chandra reposted

While FDA review is often described as increasing costs and perhaps slowing flow of new products, by certifying quality, this review can grow market size and innovation incentives, from Benjamin Berger, @amitabhchandra2, and @c_garthwaite nber.org/papers/w28889

nberpubs's tweet image. While FDA review is often described as increasing costs and perhaps slowing flow of new products, by certifying quality, this review can grow market size and innovation incentives, from Benjamin Berger, @amitabhchandra2, and @c_garthwaite nber.org/papers/w28889

Amitabh Chandra reposted

I thought health economics deserved its own... let me know what I missed! No shade meant for any of these papers, of course. #healthecon Original source of comic: xkcd.com/2456/

Mark_Meiselbach's tweet image. I thought health economics deserved its own... let me know what I missed! No shade meant for any of these papers, of course. #healthecon

Original source of comic: xkcd.com/2456/

Amitabh Chandra reposted

A quick thread on our new @tradeoffspod episode out today about the HIV prevention pill PrEP. It’s a story of the best and worst of the US drug system in one drug. 1/ tradeoffs.org/2021/04/22/pre…


Amitabh Chandra reposted

FDA should have led J&J #covid19 vaccine decision-making, former commissioner @ScottGottliebMD writes in @WSJ. “Putting the is­sue be­fore the CDC con­fused the process and slowed the de­ci­sion.” wsj.com/articles/drug-…


"Imagine if AstraZeneca and Merck were the only ones who had taken up the vaccine challenge...We’d be screwed.” @DhruvKhullar dazzles in @NewYorker newyorker.com/science/annals…


Amitabh Chandra reposted

“When it comes to something like vaccines, you don’t want the best deal,” he said. “You don’t want to pay the minimum price. You want to overpay and attract the attention of many companies simultaneously.” @amitabhchandra2 speaking truth: newyorker.com/science/annals…


Amitabh Chandra reposted

The strong Novavax results in UK - 90% overall effectiveness; 96% w original COVID; 86% w #B117 - indicate we will soon get a 4th vaccine. Amazing. And it adds extra insurance to Biden’s promise to have enough vaccine for all US adults by end of May. novavax.com/sites/default/…

Atul_Gawande's tweet image. The strong Novavax results in UK - 90% overall effectiveness; 96% w original COVID; 86% w #B117 - indicate we will soon get a 4th vaccine.

Amazing. 

And it adds extra insurance to Biden’s promise to have enough vaccine for all US adults by end of May. novavax.com/sites/default/…

Amitabh Chandra reposted

I don't really know what this means but it sounds cool

machine learning is just linear algebra for people who read the new yorker



Amitabh Chandra reposted

These behind-the-scenes vetoes happen without patient consent: current and future cancer patients (ie, many of us) would not agree this is in our best interest

So, you want to lead a randomized trial? I ran a poll: How many people have near veto power over the approval & design of an investigator initiated oncology randomized trial? Only 23% guessed right. Answer: >50! @RielyMD @mtmdphd Here are the steps to do an RCT? Thread 1/



Amitabh Chandra reposted

@UM_VBID told me that my earlier tweet about the 2021 vbid summit vbidcenter.org/2021-virtual-v… would not get as many likes as the tweet by @PatrickConwayMD. He was right. So I try again by tagging @amitabhchandra2, whose twitter reach dwarfs mine


Amitabh Chandra reposted

To reprise a relevant comment from Don Rubin on this topic: It's easy to signal mathematical aptitude but hard to convey wisdom; we conflate the two, which are not at all the same, even though we care mostly about the latter.


Amitabh Chandra reposted

Who leaked video from our last Bioworks party?

What biotech investors imagine when you tell them you do basic research



Loading...

Something went wrong.


Something went wrong.